Patents
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
02/2014
02/27/2014CA2876690A1 Dihydropyrimidine compounds and their application in pharmaceuticals
02/26/2014EP2699569A2 Aminopyrimidine kinase inhibitors
02/26/2014EP2699564A1 Substituted pyrimidinyl-pyrroles active as kinase inhibitors
02/26/2014EP2699563A1 Novel pesticidal pyrazole compounds
02/26/2014EP2699561A1 Androgen receptor modulating carboxamides
02/26/2014EP2699547A1 5-(phenyl/pyridinyl-ethinyl)-2-pyridine/ 2-pyrimidine-carborxamides as mglur5 modulators
02/26/2014EP2699545A1 Novel amino-pyrroline derivatives, and use thereof in the prevention and/or treatment of metabolic syndrome
02/26/2014CN103608343A Crystalline forms and processes for preparation of condensed azacycles (cannabinoid receptor modulators)
02/26/2014CN103608336A 9-[4-(3-chlor-2-fluor-phenylamino)-7-methoxy-quinazolin-6-yloxy]-1,4-diaza-spiro[5.5]undecan-5-one dimaleate, use thereof as a drug, and production thereof
02/26/2014CN103608335A Pyrimidine derivatives for the treatment of viral infections
02/26/2014CN103608333A 雄激素受体拮抗剂及其用途 Androgen receptor antagonists and their use
02/26/2014CN103601720A Solid salt forms of a pyrrole substituted 2-indolinone
02/26/2014CN103601684A 5-arylselenobenzimidazole compound and application thereof
02/26/2014CN102725283B Compounds and compositions as protein kinase inhibitors
02/26/2014CN102666530B Imatinib dichloroacetate and anti-cancer agent comprising the same
02/25/2014US8658654 Receptor-type kinase modulators and methods of use
02/25/2014US8658647 Integrin-linked kinase inhibitors
02/25/2014US8658635 Benzpyrazol derivatives as inhibitors of PI3 kinases
02/25/2014US8658207 Extended release tablet formulations of flibanserin and method for manufacturing the same
02/25/2014CA2777632C Imidazole derivatives as casein kinase inhibitors
02/25/2014CA2630410C 2,4,5-triphenyl imidazoline derivatives as inhibitors of the interaction between p53 and mdm2 proteins for use as anticancer agents
02/20/2014WO2014028801A1 Cyclopentylpyrazoles as n-type calcium channel blockers
02/20/2014WO2014028459A1 1,4-disubstituted pyridazine analogs and methods for treating smn-deficiency-related conditions
02/20/2014WO2014027814A1 Novel compound and organic electroluminescent device comprising same
02/20/2014WO2014027676A1 Organic electroluminescence element
02/20/2014WO2014027209A1 Pyrazolyl-ureas as kinase inhibitors
02/20/2014WO2014027053A1 Benzimidazoles for the treatment of cancer
02/20/2014WO2014026997A1 2,3-benzodiazepines
02/20/2014WO2014026880A1 Arylethynyl pyrimidines
02/20/2014WO2014026467A1 Bicyclic substituted pyrimidine compounds
02/20/2014WO2014026330A1 3-AMINOCYCLOALKYL COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF
02/20/2014WO2014026329A1 N-alkylated indole and indazole compounds as rorgammat inhibitors and uses thereof
02/20/2014WO2014026328A1 3-cyclohexenyl substituted indole and indazole compounds as rorgammat inhibitors and uses thereof
02/20/2014WO2014026327A1 4-heteroaryl substituted benzoic acid compounds as rorgammat inhibitors and uses thereof
02/20/2014WO2014026243A1 Vegfr3 inhibitors
02/20/2014WO2014026242A1 Vegfr3 inhibitors
02/20/2014WO2013170068A3 Nuclear transport modulators and uses thereof
02/20/2014WO2012145617A9 Aminopyrimidine kinase inhibitors
02/20/2014WO2009021750A3 Benzoxazole, benzimidazole and benzothiazole derivatives and their use in the treatment of duchenne muscular dytrophy
02/20/2014US20140051863 Fluorescent probes for detection of copper
02/20/2014US20140051857 Heterocyclic compounds and thrombopoietin receptor activators
02/20/2014US20140051729 Compositions and methods for treating degenerative muscle conditions
02/20/2014US20140051708 Pyrazolyl-pyrimidine derivatives as kinase inhibitors
02/20/2014US20140051703 Thiopyrimidine-based compounds and uses thereof
02/20/2014US20140051681 Mst1 kinase inhibitors and methods of their use
02/20/2014US20140051680 Histone Deacetylase Inhibitors
02/20/2014US20140051679 Kinase inhibitors and method of treating cancer with same
02/20/2014US20140051675 Modulators of cellular adhesion
02/20/2014US20140051674 New compounds
02/20/2014US20140051672 1,4-disubstituted pyridazine analogs there of and methods for treating smn-deficiency-related conditions
02/20/2014US20140051665 Prostate cancer therapy with hsp90 inhibitory compounds
02/20/2014US20140051660 Cyclopentylpyrazoles as n-type calcium channel blockers
02/20/2014US20140051656 Antiviral compounds
02/20/2014DE102012016908A1 Tris-(Hetero)Aryl-Pyrazole und ihre Verwendung Tris (hetero) aryl pyrazoles and their use
02/19/2014EP2698368A1 Novel pyrazole derivative
02/19/2014EP2698367A1 Benzimidazoles for the treatment of cancer
02/19/2014EP2698062A1 Inhibitors of poly(adp-ribose)polymerase
02/19/2014EP2697216A1 Novel compounds for organic electronic material and organic electroluminescent device using the same
02/19/2014EP2697214A1 Substituted vinyl and alkinyl cyclohexenols as active agents against abiotic stress in plants
02/19/2014EP2697206A1 Heterocyclic compounds and uses thereof in the treatment of sexual disorders
02/19/2014EP2697197A1 Pyrrolo sulfonamide compounds for modulation of orphan nuclear receptor rar-related orphan receptor-gamma (rorgamma, nr1f3) activity and for the treatment of chronic inflammatory and autoimmune diseases
02/19/2014EP2696688A1 Use of substituted dithiine-dicarboximides for combating phytopathogenic fungi
02/19/2014CN103596943A Hydantoin derivates as Kv3 inhibitors
02/19/2014CN103596941A Anti-viral compounds
02/19/2014CN103596929A Pyrazolyl and pyrimidinyl tricyclic enones as antioxidant inflammation modulators
02/19/2014CN103596928A Neprilysin inhibitors
02/19/2014CN103588756A Preparation method of trityl olmesartan
02/19/2014CN103588718A Novel triazinedione derivatives as GABAB receptor modulators
02/19/2014CN102036983B Process for the preparation of 5-(2-amino-pyrimidin-4-yl)-2-aryl-1h-pyrrole-3-carboxamides
02/18/2014US8653262 CCR2 receptor antagonists and uses thereof
02/18/2014US8653127 Bicyclic pyrazolo-heterocycles
02/18/2014US8653112 Substituted pyrazoles as estrogen receptor ligands
02/18/2014US8653084 Hydrobenzamide derivatives as inhibitors of Hsp90
02/18/2014US8653077 Inhibitors of human phosphatidylinositol 3-kinase delta
02/18/2014US8653070 Hepatitis C virus inhibitors
02/18/2014US8653062 Compounds as receptor modulators with therapeutic utility
02/18/2014US8652654 Biscarbazole derivative, material for organic electroluminescence device and organic electroluminescence device using the same
02/18/2014CA2743264C Tetrasubstituted pyridazines hedgehog pathway antagonists
02/18/2014CA2577061C Histamine h3 receptor agents, preparation and therapeutic uses
02/18/2014CA2564076C Chemical linkers and conjugates thereof
02/13/2014WO2014026009A2 Inhibition of antimicrobial targets with reduced potential for resistance
02/13/2014WO2014025976A1 Heteroaromatic compounds as bruton's tyrosine kinase (btk) inhibitors
02/13/2014WO2014025942A1 Nmda receptor modulators and uses related thereto
02/13/2014WO2014025850A1 Tricyclic amidine derivatives as hiv attachment inhibitors
02/13/2014WO2014025808A1 Curcumin analogs
02/13/2014WO2014025759A1 Iap antagonists
02/13/2014WO2014025128A1 N2,n4-bis(4-(piperazine-1-yl)phenyl)pirimidine-2,4-diamine derivative or pharmaceutically acceptable salt thereof, and composition containing same as active ingredient for preventing or treating cancer
02/13/2014WO2014024993A1 Piperazine derivative and use thereof
02/13/2014WO2014023723A1 Subtituted azines as pesticides
02/13/2014WO2014023691A1 Dihydroxypyrimidine carbonic acid derivatives and their use in the treatment, amelioration or prevention of a viral disease
02/13/2014WO2014023531A1 Trifluoromethylpyridine carboxamides as pesticides
02/13/2014WO2013190569A3 Novel salts of sunitinib and preparation thereof
02/13/2014US20140046053 Neprilysin inhibitors
02/13/2014US20140045910 Novel amino-pyrroline derivatives, and use thereof in the prevention and/or treatment of metabolic syndrome
02/13/2014US20140045862 Cycloalkane Derivatives
02/13/2014US20140045849 Pyrimidine derivatives for the treatment of viral infections
02/13/2014US20140045848 Thiopyrimidine-based compounds and uses thereof
02/13/2014US20140045845 Novel pyrimidine derivatives
02/13/2014US20140045838 Kinase inhibitors and method of treating cancer
02/13/2014US20140045822 Kinase inhibitors and method of treating cancer with same
1 ... 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 ... 626